Form D · Biotechnology
Renalysis Medical Products, Inc.
Buffalo Grove, IL · CIK 0001708445
Offering snapshot reported Jul 24, 2017 · SEC filing
- Reported sold
- $400K Offering amount: $400K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $400K Reported outside-investor minimum
- First sale
- Jul 21, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 24, 2017 | Initial | $400,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity, Debt
- Exemptions
- 04, 06b
- Duration over one year
- No
- Business combination
- Yes
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-291322
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| N/A | None |
Source: Form D, filed Jul 24, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Xingcai Sun | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1548 Barclay Boulevard
Buffalo Grove, IL, 60089
Buffalo Grove, IL, 60089